1. Home
  2. SUPV vs PHAT Comparison

SUPV vs PHAT Comparison

Compare SUPV & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Supervielle S.A. each Representing five Class B shares

SUPV

Grupo Supervielle S.A. each Representing five Class B shares

HOLD

Current Price

$8.69

Market Cap

770.4M

Sector

Finance

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$9.28

Market Cap

759.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPV
PHAT
Founded
1887
2018
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
770.4M
759.7M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
SUPV
PHAT
Price
$8.69
$9.28
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$13.00
$19.83
AVG Volume (30 Days)
662.2K
1.2M
Earning Date
05-26-2026
04-30-2026
Dividend Yield
2.19%
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
$86.20
$93.04
Revenue Next Year
$25.12
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$4.54
$8.21
52 Week High
$13.55
$18.31

Technical Indicators

Market Signals
Indicator
SUPV
PHAT
Relative Strength Index (RSI) 50.77 45.61
Support Level $7.70 $8.46
Resistance Level $8.92 $9.75
Average True Range (ATR) 0.44 0.48
MACD 0.12 0.11
Stochastic Oscillator 77.27 49.44

Price Performance

Historical Comparison
SUPV
PHAT

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA a diversified financial services group in Argentina. It offers a broad range of financial products and services including lending, savings and investments, insurance, payments and cash management services, car loans, and asset management, positioning itself as a one-stop destination for financial needs. It operates exclusively in Argentina, through the Bank, which serves as its main banking subsidiary, delivering a comprehensive suite of financial services to retail, SMEs and corporate customers. Its segments include Personal & Business Banking; Corporate Banking; Bank Treasury; Insurance; and Asset Management and Other Services (which includes IOL invertironline). The majority of the revenue is derived from Personal & Business Banking segment.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: